MedTrace Logo

Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye

NCT04091581 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2022-06-22

Study results available
· View outcomes & findings →

Summary

The objective of the study is to compare the rate of tear evaporation, measured with a novel evaporimeter, before and for one hour after an eye drop containing nano-sized oil droplets has been instilled.

Conditions

  • Evaporative Dry Eye

Interventions

DRUG

Systane Complete

Systane Complete will be instilled and rate of evaporation assessed before and after.

Sponsors & Collaborators

  • University of Waterloo

    lead OTHER

Principal Investigators

  • Lyndon Jones, PhD, FCOptom · Centre for Ocular Research & Education

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-21
Primary Completion
2020-02-06
Completion
2020-02-06
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091581 on ClinicalTrials.gov